5th Sep 2008 07:00
|
For immediate release |
5 September 2008 |
Futura Medical plc
Notification of Interim Results
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that its interim results for the half year ended 30 June 2008 will be announced on Friday 19 September 2008.
A meeting for analysts will be held at 10am on 19 September 2008 at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.
For further information:
|
Futura Medical plc |
|
|
James Barder, Chief Executive |
Tel: +44 (0) 1483 685 670 |
|
mail to: [email protected] |
www.futuramedical.co.uk |
Media enquiries:
|
Buchanan Communications |
|
|
Mark Court / Rebecca Skye Dietrich |
Tel: +44 (0) 20 7466 5000 |
Nominated Adviser:
|
Canaccord Adams Limited |
|
|
Ryan Gaffney / Adria Da Breo-Richards |
Tel: +44 (0) 20 7050 6500 |
Notes
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.co.uk
Related Shares:
Futura Medical